Dupixent (Dupilumab) Injection Package Insert

This document is the official package insert for Dupixent (Dupilumab) Injection, detailing its use for moderate-to-severe atopic dermatitis in patients aged…


Dupixent (Dupilumab) Injection Package Insert - cover page
Brand
Sanofi
Category
Other
Document type
User Manual
Language
Chinese
Pages
35
File format
PDF
File size
2 MB
Published
14 October, 2026
Updated
14 October, 2026
MD5 checksum
984F04F8EBC1EE9DF2DC6D9074025833

About this manual

This document serves as the official instruction and information leaflet for Dupixent (Dupilumab) Injection, a monoclonal antibody used to treat moderate-to-severe atopic dermatitis. It provides comprehensive guidance on the drug's composition, indications, and specific usage protocols for both adults and adolescents aged 12 to 17 years.

The text outlines detailed dosing regimens based on patient weight and age, specifying initial doses of 600mg for adults and 400mg or 600mg for adolescents, followed by maintenance doses every two weeks. It also covers administration methods, such as subcutaneous injection into the thigh or abdomen, and provides critical safety information regarding adverse reactions, contraindications, and precautions for special populations like pregnant women and those with renal impairment. This manual is written in Chinese.

What's inside

  • 药品名称
  • 成份
  • 适应症
  • 规格
  • 用法用量
  • 给药方法
  • 不良反应
  • 禁忌
  • 注意事项
  • 药物相互作用

Specifications

Active IngredientDupilumab
Dosage FormPre-filled syringe
Strength (Adult)300 mg (2.0 mL)/ 支
Strength (Adolescent)200mg (1.14 mL)/ 支

Frequently asked questions

What is the recommended initial dose for adults?

The recommended initial dose for adults is 600mg, administered as two 300mg injections.

How often should the medication be administered after the initial dose?

Subsequent doses should be given once every two weeks at 300mg.

What is the initial dose for adolescents weighing 30kg to less than 60kg?

The initial dose is 400mg, administered as two 200mg injections.

Where should the injection be administered?

The injection should be given subcutaneously into the thigh or abdomen, excluding the area within 5cm of the navel.

Download PDF (2 MB)

More Sanofi Manuals


View all Sanofi manuals →